Garry Fenton

821 total citations
21 papers, 512 citations indexed

About

Garry Fenton is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Garry Fenton has authored 21 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Garry Fenton's work include Microbial Natural Products and Biosynthesis (5 papers), Asymmetric Synthesis and Catalysis (5 papers) and Synthesis and Catalytic Reactions (4 papers). Garry Fenton is often cited by papers focused on Microbial Natural Products and Biosynthesis (5 papers), Asymmetric Synthesis and Catalysis (5 papers) and Synthesis and Catalytic Reactions (4 papers). Garry Fenton collaborates with scholars based in United Kingdom, United States and Switzerland. Garry Fenton's co-authors include David W. Knight, Frank Bennett, Andrew D. Smith, Steven D. Bull, Stephen G. Davies, Andrew W. Mulvaney, Duncan Shaw, David W. Knight, David Cook and Andrew J. Ratcliffe and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Garry Fenton

21 papers receiving 476 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Garry Fenton 378 192 95 69 45 21 512
Tatsuo Tsuri 403 1.1× 164 0.9× 165 1.7× 43 0.6× 42 0.9× 16 544
Tooru Kuroda 621 1.6× 261 1.4× 81 0.9× 66 1.0× 78 1.7× 28 772
Patrick Bernardelli 358 0.9× 175 0.9× 118 1.2× 95 1.4× 24 0.5× 17 509
S. Kodato 282 0.7× 257 1.3× 82 0.9× 42 0.6× 37 0.8× 16 505
Toshiyasu Takemoto 388 1.0× 205 1.1× 36 0.4× 26 0.4× 26 0.6× 18 523
Reiko Kawahama 536 1.4× 235 1.2× 106 1.1× 85 1.2× 31 0.7× 18 736
M. E. Layton 428 1.1× 264 1.4× 79 0.8× 57 0.8× 18 0.4× 20 647
David M. Hollinshead 320 0.8× 119 0.6× 42 0.4× 50 0.7× 23 0.5× 17 450
Benjamin Pelcman 568 1.5× 162 0.8× 58 0.6× 54 0.8× 19 0.4× 23 698
Katsuichi Shimoji 420 1.1× 111 0.6× 59 0.6× 25 0.4× 55 1.2× 15 516

Countries citing papers authored by Garry Fenton

Since Specialization
Citations

This map shows the geographic impact of Garry Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Fenton more than expected).

Fields of papers citing papers by Garry Fenton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Fenton. The network helps show where Garry Fenton may publish in the future.

Co-authorship network of co-authors of Garry Fenton

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Fenton. A scholar is included among the top collaborators of Garry Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Fenton. Garry Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Namoto, Kenji, Finton Sirockin, Nils Ostermann, et al.. (2014). Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry Letters. 24(3). 731–736. 15 indexed citations
2.
Bull, Steven D., et al.. (2000). Chemoselective debenzylation of N-benzyl tertiary amines with ceric ammonium nitrate. Journal of the Chemical Society Perkin Transactions 1. 3765–3774. 75 indexed citations
3.
Fenton, Garry, et al.. (1996). On the stereoselection of iodolactonizations of 3-silyloxyalk-5-enoic acids. Journal of the Chemical Society Perkin Transactions 1. 1505–1505. 6 indexed citations
4.
Ashton, Michael J., Thomas J. Brown, Garry Fenton, et al.. (1996). New Low-Density Lipoprotein Receptor Upregulators Acting via a Novel Mechanism. Journal of Medicinal Chemistry. 39(17). 3343–3356. 8 indexed citations
5.
Ashton, Michael J., David Cook, Garry Fenton, et al.. (1994). Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs. Journal of Medicinal Chemistry. 37(11). 1696–1703. 93 indexed citations
6.
Bennett, Frank, Garry Fenton, & David W. Knight. (1994). Synthesis of conformationally restricted relatives of the mevinic acids. Tetrahedron. 50(17). 5147–5158. 6 indexed citations
8.
Shaw, Duncan, Garry Fenton, & David W. Knight. (1994). A radical cyclisation approach to the 2-oxabicyclo[2.2.1]heptane ring system. Journal of the Chemical Society Chemical Communications. 2447–2447. 1 indexed citations
9.
Knight, David W., et al.. (1994). An Asymmetric Synthesis of Muscarine, Suitable for the Elaboration of 5- Substituted Analogues. Synlett. 1994(4). 295–296. 14 indexed citations
10.
Bridge, Andrew W., Garry Fenton, Frank Halley, et al.. (1993). Synthesis of 1,3-disubstituted-pyrrolo[2,1-a]isoquinoline-2-carboxylic acids, esters and amides. Journal of the Chemical Society Perkin Transactions 1. 2761–2761. 8 indexed citations
11.
Fenton, Garry, et al.. (1992). Stereoselection in iodolactonisations of 3-silyloxy-5-alkenoic acids. Tetrahedron Letters. 33(43). 6505–6506. 10 indexed citations
12.
Fenton, Garry, et al.. (1992). Iodoetherification of homoallylic alcohols : A stereoselective approach to tetrahydrofurans. Tetrahedron Letters. 33(43). 6511–6514. 36 indexed citations
13.
Bennett, Frank, et al.. (1992). Iodine-induced cyclisations of (E)- and (Z)-3-hydroxy-5-alkenoates: Stereoselective approaches to trisubstituted tetrahydrofurans. Tetrahedron Letters. 33(43). 6507–6510. 22 indexed citations
14.
Bennett, Frank, David W. Knight, & Garry Fenton. (1991). Total syntheses of natural (+)-(4R,6R)-4-hydroxy-6-pentylvalerolactone and of (–)-(6R)-massoialactone. Journal of the Chemical Society Perkin Transactions 1. 1543–1547. 26 indexed citations
15.
Bennett, Frank, David W. Knight, & Garry Fenton. (1991). An alternative approach to mevinic acid analogues from methyl (3R)-(–)-3-hydroxyhex-5-enoate and an extension to unambiguous syntheses of (6R)-(+)-and (6S)-(–)-goniothalamin. Journal of the Chemical Society Perkin Transactions 1. 519–523. 15 indexed citations
16.
Bennett, Frank, David W. Knight, & Garry Fenton. (1991). Methyl (3R)-3-hydroxyhex-5-enoate as a precursor to chiral mevinic acid analogues. Journal of the Chemical Society Perkin Transactions 1. 133–133. 28 indexed citations
17.
18.
Knight, David W., Frank Bennett, & Garry Fenton. (1989). Enantioselective Total Syntheses of (4R,6R)-(+)-4-Hydroxy-6-pentylvalerolactone, ex Cephalosporium recifei, and of (6R)-(—)-Massoialactone. Heterocycles. 29(4). 639–639. 19 indexed citations
19.
Bennett, Frank, David W. Knight, & Garry Fenton. (1988). Chiral synthons for the elaboration of mevinic acid analogues. Tetrahedron Letters. 29(38). 4865–4868. 13 indexed citations
20.
Parkes, J. D., Garry Fenton, G. Curzon, et al.. (1974). Narcolepsy and Cataplexy. Clinical Features, Treatment and Cerebrospinal Fluid Findings. QJM. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026